1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

ADC mapping of lymphomas and carcinomas in the nasopharynx and oropharynx
ADC Mapping (× 10⁻³ mm²/s) Percentage of Tumor Area on ADC Map
Nasopharynx Oropharynx
Lymphoma NPC Lymphoma PD SCC MD SCC WD SCC
T2 Homo T2 Hetero T2 Homo T2 Hetero 
No. of patients 7 8 17 5 4 3 5 7
Extremely low (<0.6) 68 ± 15 57 ± 12 51 ± 35^a,^b,^c,^d 34 ± 25 10 ± 5^a,^b 24 ± 25 15 ± 13^a,^c 15 ± 22^a,^d
Low (0.6–1.2) 32 ± 14 43 ± 12 48 ± 34 64 ± 25 74 ± 7 75 ± 26 68 ± 18 63 ± 14
Intermediate (1.2–1.8) 0 ± 0 1 ± 1 1 ± 2^a,^e,^f 1 ± 2^a,^g 16 ± 10^a,^e,^g 2 ± 2 15 ± 19^a,^f 19 ± 15
High (>1.8) 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 0 ± 0 2 ± 3 3 ± 5

Note:—PD, poorly differentiated, MD, moderately differentiated; Homo, homogeneous; Hetero, heterogeneous; WD, well-differentiated; T2 homo/hetero, with homogeneous/heterogeneous T2 signals.


↵a Significant differences between lymphomas and SCCs, and between PD SCCs with homogeneous T2 signals and heterogeneous T2 signals (Mann-Whitney U test).


↵b P = .040.


↵c P = .048.


↵d P = .011.


↵e P = .001.


↵f P < .001.


↵g P = .019.